Bodhi Tree net loss narrows to $29,195 in Q3 FY26; revenue turns to $15,000

BODHI TREE BIOTECHNOLOGY INC

BDTB

0.00

Bodhi Tree Biotechnology posted a net loss of USD 29,195 for the three months ended March 31, 2026, narrowing from USD 53,428 a year earlier as revenue turned to USD 15,000 from no revenue.
General and administrative expenses fell 17.66% to USD 42,934 from the year-ago quarter.
For the six months ended March 31, net loss narrowed to USD 82,144 from USD 118,205 as revenue more than doubled to USD 15,000.
Cash used in operating activities totaled USD 86,654 for the six months ended March 31.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bodhi Tree Biotechnology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001829126-26-005192), on May 14, 2026, and is solely responsible for the information contained therein.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.